Literature DB >> 3710192

Divergence pseudoparalysis: a case report.

M Nardi, G Dal Pozzo, A Romani, L Barca.   

Abstract

Divergence paralysis is a clinical syndrome that is characterized by esotropia and diplopia at distance fixation and fusion at near fixation. This syndrome is thought to result from a lesion in the brain stem, probably in the midbrain or in the pontine region. This paper reports a case in which ocular motility disturbances, simulating divergence paralysis, were caused by a bilateral and symmetrical restrictive syndrome involving the medial rectus muscles.

Entities:  

Mesh:

Year:  1986        PMID: 3710192     DOI: 10.1007/bf02150032

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  7 in total

1.  Paralysis of Divergence.

Authors:  E M Alger
Journal:  Trans Am Ophthalmol Soc       Date:  1916

2.  Divergence paralysis with increased intracranial pressure; further observations.

Authors:  M CHAMLIN; L M DAVIDOFF
Journal:  AMA Arch Ophthalmol       Date:  1951-08

3.  Divergence paralysis.

Authors:  R D Cunningham
Journal:  Am J Ophthalmol       Date:  1972-10       Impact factor: 5.258

4.  Divergence paralysis following head trauma.

Authors:  P C Rutkowski; H M Burian
Journal:  Am J Ophthalmol       Date:  1972-05       Impact factor: 5.258

5.  Ocular divergence mechanisms.

Authors:  A Jampolsky
Journal:  Trans Am Ophthalmol Soc       Date:  1970

6.  Divergence paralysis.

Authors:  P M Moller
Journal:  Acta Ophthalmol (Copenh)       Date:  1970

7.  Divergence paralysis.

Authors:  G B Krohel; D R Tobin; M E Hartnett; N A Barrows
Journal:  Am J Ophthalmol       Date:  1982-10       Impact factor: 5.258

  7 in total
  2 in total

1.  Medial rectus recession is as effective as lateral rectus resection in divergence paralysis esotropia.

Authors:  Zia Chaudhuri; Joseph L Demer
Journal:  Arch Ophthalmol       Date:  2012-10

2.  Acute Acquired Comitant Esotropia in Adults: Is It Neurologic or Not?

Authors:  Kadriye Erkan Turan; Tulay Kansu
Journal:  J Ophthalmol       Date:  2016-11-27       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.